
PCN9 VALIDITY OF PROPORTIONAL HAZARDS (PH) WEIBULL MODELS FOR ANALYZING PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2+ (HER2+) METASTATIC BREAST CANCER (MBC) RECEIVING LAPATINIB PLUS CAPECITABINE (L+C) VERSUS CAPECITABINE ONLY (C-ONLY)
O Sofrygin, T Delea, P Tappenden, J Karnon, MM Amonkar, M WalkerVolume:
11
Année:
2008
Langue:
english
DOI:
10.1016/s1098-3015(10)70189-3
Fichier:
PDF, 69 KB
english, 2008